PRAN Key Stats
- Alzheimer's Research Stocks - Technical And Other Considerations Yahoo 03/07 08:38 ET
- Prana’s Alzheimer’s Disease Treatment Strategy Validated by Independent Study Other 03/06 18:07 ET
- Prana Biotech (PRAN) Reports Positive Data Published on PoC MPAC for Alzheimer's Disease Street Insider 03/06 09:11 ET
- Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take? Yahoo 03/04 15:24 ET
- Prana: Right Drug, Wrong Dose Yahoo 03/03 09:38 ET
- A Busy Calendar of March Biotech Events The Street 03/03 08:13 ET
- The Best- And Worst-Performing Biotech Stocks, Feb. 21 to Feb. 28 Yahoo 03/02 11:58 ET
- 3 Humongous Health-Care Stocks This Week Yahoo 03/01 07:31 ET
- Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results Yahoo 03/01 06:45 ET
- Unusual 11 Mid-Day Movers 02/26: (CNET) (ANIK) (PRAN) Higher; (FST) (UTIW) (DGI) Lower Street Insider 02/26 12:58 ET
PRAN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Prana Biotechnology is up 310.0% over the last year vs S&P 500 Total Return up 24.21%, Galena Biopharma up 69.70%, and MannKind up 103.2%.
Balance Sheet View Statement
Pro Ratings for PRAN
Pro Strategies Featuring PRAN
Did Prana Biotechnology make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: Australia
- Headquarters State/Province: N/A
- Incorporation Country: Australia
- Incorporation State/Province: N/A
Prana Biotechnology Limited is a development stage company at an early stage in the development of its pharmaceutical products. The Company’s activities include research into Alzheimer ’s disease and other major age-related degenerative disorders.